With 0.44 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.59 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $7.555 whereas the lowest price it dropped to was $7.05. The 52-week range on SIGA shows that it touched its highest point at $12.83 and its lowest point at $3.97 during that stretch. It currently has a 1-year price target of $11.00. Beta for the stock currently stands at 0.89.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SIGA was up-trending over the past week, with a rise of 17.76%, but this was up by 3.52% over a month. Three-month performance dropped to -19.83% while six-month performance fell -1.08%. The stock gained 50.50% in the past year, while it has gained 41.09% so far this year. A look at the trailing 12-month EPS for SIGA yields 1.20 with Next year EPS estimates of 1.26. EPS is expected to grow by 1.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -28.78%.
Float and Shares Shorts:
At present, 71.09 million SIGA shares are outstanding with a float of 40.53 million shares on hand for trading. On 2024-11-15, short shares totaled 3.53 million, which was 495.0 higher than short shares on 1728950400. In addition to Mr. Daniel J. Luckshire CPA as the firm’s Executive VP, CFO & Secretary, Dr. Dennis E. Hruby Ph.D. serves as its Executive VP & Chief Scientific Officer.
Institutional Ownership:
Through their ownership of 0.52916 of SIGA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, SIGA reported revenue of $10009781.0 and operating income of $542087.0. The EBITDA in the recently reported quarter was $670469.0 and diluted EPS was $0.02.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of $1.05 being high and $1.05 being low. For SIGA, this leads to a yearly average estimate of $1.05. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
